魏裕双，2011年本科毕业于华中科技大学，2017年于华中科技大学获得博士学位，博士期间（2013.10-2014.1）作为国际交换生在美国华盛顿的Howard University交流学习。博士毕业先后在美国Sanford Burnham Prebys Medical Discovery Institute和明尼苏达大学药学院从事博士后研究员，2022年10月加入松山湖材料实验室，纳米生物材料团队副研。

发表文章：

13. Yushuang Wei, Haibo Chen, Yuexuan Li, Kejie He, Kai Yang and Hongbo Pang. 

    Synergistic Entry of Individual Nanoparticles into Mammalian Cells Driven by Free Energy Decline and Regulated by Their Sizes.

     ACS Nano 2022, 16(4), 5885-5897.

12. Xian Wu, Tang Tang, Yushuang Wei, Katherine A. Cummins, David K. Wood and Hongbo Pang.

    Extracellular Vesicles Mediate the Intercellular Exchange of Nanoparticles. 

    Adv Sci 2022, 9 (7), e2102441.

11. Jibin Guan, Hong Guo, Tang Tang, Yihan Wang, Yushuang Wei, Punit. Seth, Yingming Li, Scott M. Dehm, Erkki Ruoslahti and Hongbo Pang. 

    iRGD-liposomes enhance tumor delivery and therapeutic efficacy of antisense oligonucleotide drugs against primary prostate cancer and bone metastasis. 

    Adv Funct Mater 2021, 31 (24).

10. Kejie He, Yushuang Wei, Zhihong Zhang, Haibo Chen, Bing Yuan, Hongbo Pang and Kai Yang. 

    Membrane-curvature-mediated co-endocytosis of bystander and functional nanoparticles. 

    Nanoscale 2021, 13 (21), 9626-9633.

9. Yuexuan Li, Yushuang Wei, Rui Zhong, Ling Li and Hongbo Pang. 

    Transportan Peptide Stimulates the Nanomaterial Internalization into Mammalian Cells in the Bystander Manner through Macropinocytosis.

    Pharmaceutics 2021, 13 (4): 552.

8. Tang Tang, Yushuang Wei, Qinglin Yang, Ying Yang, Michael J. Sailor and Hongbo Pang.

     Rapid chelator-free radiolabeling of quantum dots for in vivo imaging.

     Nanoscale 2019, 11 (46), 22248-22254.

7. Yushuang Wei, Tang Tang and Hongbo Pang.

     Cellular internalization of bystander nanomaterial induced by TAT-nanoparticles and regulated by extracellular cysteine. 

     Nat Commun 2019, 10 (1), 3646.

6. Tang Tang, Yushuang Wei, Jinyoung Kang, Zhi-Gang She, Dokyoung Kim, Michael J. Sailor, Erkki Ruoslahti and Hongbo Pang. 

    Tumor-specific macrophage targeting through recognition of retinoid X receptor beta. 

    Journal of controlled release 2019, 301, 42-53.

5. Renwei Jing, Xiaoli Zhou, Jingwen Zhao, Yushuang Wei, Bingfeng Zuo, Abin You, Quan Rao, Xianjun Gao, Rong Yang, Lu Chen, Zhen Lu, Qibing Zhou, Ning Zhang and Haifang Yin,

    Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and human in vitro, 

    Hepatology. 2018, 68(4): 1391-1411.

4. Yushuang Wei, Rufang Liao, Abdulrahman A Mahmood, Haibo Xu and Qibing Zhou, 

     pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent, 

     Acta Biomater 55 (2017) 194-203.

3. Qibing Zhou and Yushuang Wei. For Better or Worse,

     Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases. 

     Chemical research in toxicology 2017, 30 (1), 73-80.

2. Yushuang Wei, Mengzhu Zhao, Fang Yang, Yang Mao, Hang Xie and Qibing Zhou.

     Iron Overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment. 

     Scientific Reports, 2016, 6: 29110.

1. Yushuang Wei, Rufang Liao, Haijuan Liu, Huan Li, Haibo Xu and Qibing Zhou. 

     Biocompatible Low-Retention Superparamagnetic Iron Oxide Nanoclusters as Contrast Agents for Magnetic Resonance Imaging of Liver Tumor. 

     J Biomed Nanotechnol 2015, 11 (5), 854-864.